To investigate if CEACAM6 expression is associated with samples with mutant KRAS, we analyzed TCGA RNA-Seq dataset of PDA samples that constitute 129 mutant KRAS and 24 WT KRAS samples. This evidence concerns the gene CEACAM6 and Patent ductus arteriosus.